Edwards Lifesciences
720 hedge funds and large institutions have $20.8B invested in Edwards Lifesciences in 2017 Q2 according to their latest regulatory filings, with 87 funds opening new positions, 227 increasing their positions, 287 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.64% more ownership
Funds ownership: 249.22% → 251.86% (+2.6%)
21% less repeat investments, than reductions
Existing positions increased: 227 | Existing positions reduced: 287
33% less call options, than puts
Call options by funds: $62.5M | Put options by funds: $93.9M
Holders
720
Holding in Top 10
14
Calls
$62.5M
Puts
$93.9M
Top Buyers
| 1 | +$388M | |
| 2 | +$218M | |
| 3 | +$104M | |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$71.9M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$59.8M |
Top Sellers
| 1 | -$163M | |
| 2 | -$107M | |
| 3 | -$85M | |
| 4 |
FAM
Fred Alger Management
New York
|
-$67.9M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$61M |